Vimarsana
Biggest News Aggregation in the World

Erasca Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Erasca Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Erasca Inc Today - Breaking & Trending Today

Global Precision Oncology Market Size To Exceed USA 260.5 - Vimarsana News

Global Precision Oncology Market Size To Exceed USA 260.5

The Global Precision Oncology Market Size was Valued at USD 98.5 Billion in 2023 and the Worldwide Precision Oncology Market Size is Expected to Reach USD...

Insider Buying: Erasca, Inc. (NASDAQ:ERAS) Director Acquires 80,000 Shares of Stock - Vimarsana News

Insider Buying: Erasca, Inc. (NASDAQ:ERAS) Director Acquires 80,000 Shares of Stock

Erasca, Inc. (NASDAQ:ERAS – Get Free Report) Director Alexander W. Casdin bought 80,000 shares of Erasca stock in a transaction that occurred on Tuesday, May 21st. The shares were acquired at an average cost of $2.27 per share, with a total value of $181,600.00. Following the acquisition, the director now owns 573,974 shares of the […]

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Erasca (NASDAQ:ERAS) - Vimarsana News

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Erasca (NASDAQ:ERAS)

e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday - e.l.f. Beauty (NYSE:ELF) - Vimarsana News

e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday - e.l.f. Beauty (NYSE:ELF)

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Erasca (NASDAQ:ERAS) - Vimarsana News

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Erasca (NASDAQ:ERAS)

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with